Delivery Order SPE2DB22D3301-SPE2DB24FY0KB
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 10 MG/ML SOLUTION 200ML. The contract has a completion date of February 16, 2024 and a potential value of $1,688.80. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award, which is not associated with any set-aside designations. The contract is part of Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 10 mg/ml solution in 200 ml containers, with a ceiling value of $1,105.15. It is a firm fixed-price delivery order contract with a period of performance ending on July 16, 2025. The contract is not set-aside for any specific business type. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VIMPAT 10 MG/ML SOLUTION 200ML. The contract has a ceiling value of $1,172.13 and a period of performance through June 10, 2025. The contract is not set aside and was awarded on a competitive basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 200ml bottles of the pharmaceutical product VIMPAT 10 MG/ML Solution. The contract has a completion date of January 22, 2024 and a potential value of $1,604.36. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,669.77 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of VIMPAT 10 mg/mL Solution in 200 mL quantities. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. The contract is scheduled for completion by December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, a $1,705.70 firm fixed price delivery order contract to provide VIMPAT 100 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,567.64, is for the delivery of VIMPAT 10 MG/ML SOLUTION 200ML, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, with a ceiling value of $1,646.10. The contract utilizes firm fixed pricing with an ultimate completion date of December 5, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide VIMPAT 100 MG TABLET 60S pharmaceutical products. The $2,384.84 contract has a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.40 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in a 200 ml volume. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, completed on September 10, 2025, with an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY0KBDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a prime contractor subsidiary of Amerisourcebergen Corporation, for the supply of VIMPAT 10 MG/ML SOLUTION 200ML. The contract has a potential value of $1,113.28 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this specific award. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/8/24 |